FindTrial
Sign In

Study on Assessment Technology of Myocardial Fibrosis

Study on Assessment Technology of Myocardial Fibrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094867
Enrollment
Unknown
Registered
2024-12-30
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart disease

Interventions

Experimental group:None
Control group:None

Sponsors

Fuzhou University Affiliated Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Cardiovascular disease patients who receive treatment at our hospital 2. Age between 18 and 75 years 3. Full civil capacity 4. Voluntary participation with signed informed consent

Exclusion criteria

Exclusion criteria: 1. Severe heart failure 2. History of myocardial infarction 3. Acute respiratory failure 4. Shock 5. Coma or other conditions unsuitable for examination 6. Pregnant or lactating women 7. Women of childbearing potential

Design outcomes

Primary

MeasureTime frame
SUV value of myocardial FAPI uptake;SUV extent of myocardial FAPI uptake;—

Countries

China

Contacts

Public ContactYuanxiang Chen

Fuzhou University Affiliated Provincial Hospital

chenyuanxiang@fjmu.edu.cn+86 158 8048 2143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026